Clinical trials
Type 1 diabetes clinical trials
An autoimmune condition where the body makes little or no insulin. We’re tracking 862 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04629586Recruiting
T1D Exchange registry for people with type 1 diabetes
This trial registry collects information about people living with type 1 diabetes to help researchers better understand the condition. It may help by allowing future studies and improving how care is studied and planned.
Boston, MassachusettsAges Any age - NCT04477928Recruiting
Checking type 1 diabetes risk using routine child care
This study estimates the chance of developing type 1 diabetes in children by using information gathered during regular well-child visits. It may help identify children who could benefit from earlier monitoring.
Bemidji, MinnesotaAges birth–17 years - NCT04039763Recruiting
Glucose monitoring for young adults at risk of DKA
This study tests a real-time glucose monitor (RT-CGM) to help young adults with insulin-treated diabetes recognize dangerously high or fast-changing blood sugars. It may help lower the risk of diabetic ketoacidosis (DKA), a serious complication that can lead to urgent care or hospital stays.
LondonAges 18–25 - NCT04096794Recruiting
Smartphone-based research study for people with type 1 diabetes
This study is a multi-site project designed for people who have type 1 diabetes and can use a smartphone app (WeChat or a similar app). It aims to collect research information in a way that’s easier to follow day to day, which may help improve future care for type 1 diabetes.
Changsha, HunanAges Any age - NCT03746769RecruitingPhase 1/Phase 2
Testing gastrin to improve results of islet cell transplant
This trial looks at whether adding gastrin can improve outcomes after an islet cell transplant for people with type 1 diabetes. It may help some participants achieve better blood sugar control, but it also requires close follow-up and immune-suppressing medications to protect the new cells.
Duarte, CaliforniaAges 18–68 - NCT03648918Recruiting
Study family genetics in type 1 diabetes
This study looks at genetic patterns in families where someone has type 1 diabetes (an autoimmune condition). It may help researchers understand why type 1 diabetes happens and who is at risk.
Milwaukee, WisconsinAges 2 years+ - NCT03585153Enrolling by invitation
Pancreas imaging study in people with type 1 diabetes
This study takes pictures of the pancreas in children and teens (and likely adults) with type 1 diabetes soon after diagnosis. The goal is to learn more about how the pancreas changes with diabetes, which may help future care.
Aurora, ColoradoAges 8 years+ - NCT03463564RecruitingPhase 4
Insulin pump versus insulin shots for type 1 diabetes control
This study compares an insulin pump to insulin shots to see which better improves blood sugar control and reduces swings in people with type 1 diabetes. You may be included if your diabetes is not well controlled despite education and you’ve had low blood sugar episodes.
NaplesAges 18–30 - NCT03132129Recruiting
Heart imaging study in adults with type 2 diabetes
This study looks for early, “silent” changes in heart function in adults with type 2 diabetes, even if you feel okay. It uses heart scans and looks for factors that may help explain why these changes happen.
LeicesterAges 50–75 - NCT02734277Recruiting
Extending a past Type 1 diabetes immune study
This study is for people who already took part in an earlier immune-tolerance program for Type 1 diabetes. It tests whether continuing follow-up and assessments can be done safely and may help learn more about long-term immune effects of treatment.
San Francisco, CaliforniaAges 8–35 - NCT02973412Recruiting
How sleep timing affects blood sugar in diabetes
This study looks at your daily sleep–wake timing (“chronotype”) and how it may affect blood sugar control in people with diabetes. It may help researchers learn whether sleep patterns could improve glucose levels.
LeicesterAges 18–75 - NCT01779115Enrolling by invitation
Diabetes registry for people with diagnosed high blood sugar
This is a research registry that collects information from people who have diabetes (high blood sugar on tests or based on diabetes treatment). It may help researchers understand diabetes patterns in a real-world healthcare system.
Tel AvivAges Any age - NCT07676565Recruiting
Adding new drugs to insulin for type 1 diabetes
This study tests whether adding certain diabetes pills (GLP-1 receptor agonists or SGLT inhibitors) to insulin is safe and helpful for adults with type 1 diabetes. Doctors will check your glucose monitor data to see how well this works.
Newport Beach, CaliforniaAges 18 years+ - NCT07667504Recruiting
Dietary approaches for weight management in type 1 diabetes
This study tests two different diet approaches to help people with type 1 diabetes who are overweight or obese manage their weight. It aims to find out which eating plan works better for blood sugar control and weight loss.
Málaga, MálagaAges 18–65 - NCT07726680Recruiting
Game for kids with new type 1 diabetes
This study tests a fun video game that connects to a continuous glucose monitor (CGM). The game helps kids newly diagnosed with type 1 diabetes learn about managing their condition in a playful way. Both the child and a parent need to join together.
Lahore, Punjab ProvinceAges 6–17 - NCT07732777Recruiting
AI-assisted insulin pump study for type 1 diabetes
This study tests whether an artificial intelligence (AI) system can help manage insulin pump therapy remotely for people with type 1 diabetes. The goal is to improve blood sugar control and make diabetes management easier.
Nanjing, JiangsuAges 14–65 - NCT07742306Recruiting
Glucose monitor study for teens with type 1 diabetes
This study tests using a continuous glucose monitor (CGM) in teenagers with type 1 diabetes in the Dominican Republic. The device tracks blood sugar levels around the clock to help manage their diabetes better. Participants will get support and education over about 15 months.
Santiago de los CaballerosAges 10–19 - NCT07767461Recruiting
Patches to prevent skin irritation from diabetes devices in kids
This trial tests whether special patches placed under insulin pumps or glucose monitors can prevent or reduce skin irritation (contact dermatitis) in children and teens with type 1 diabetes.
CopenhagenAges 2–18 - NCT07797335RecruitingPhase 3
Zenagamtide for diabetes and weight loss
This study compares a new once-weekly injection to lower blood sugar levels against a standard daily injection in people with type 2 diabetes who are at high risk for heart problems. It aims to find out if the new medicine is more effective in managing blood sugar and body weight.
Birmingham, AlabamaAges 45 years+ - NCT07662135RecruitingPhase 3
A study of elecoglipron for type 2 diabetes with kidney problems
This trial tests a new medicine called elecoglipron to see if it helps control blood sugar in people with type 2 diabetes who also have reduced kidney function. You would continue taking your current SGLT2i medication (like dapagliflozin).
Sun City, ArizonaAges 18 years+ - NCT04011020RecruitingPhase 3
Stem cell treatment for type 1 diabetes
This study tests a treatment that uses a patient's own immune cells to help the body make more insulin. It may help people with type 1 diabetes manage their blood sugar better.
Paramus, New JerseyAges 10 years+ - NCT07804849RecruitingPhase 2/Phase 3
Verapamil for newly diagnosed type 1 diabetes in youth
This study tests whether an oral blood pressure medicine called verapamil can help preserve insulin-making cells in children and teens recently diagnosed with type 1 diabetes. It may slow the disease and reduce how much insulin you need.
CairoAges 10–18 - NCT07801820RecruitingPhase 2
Oral diabetes medication study
This study tests an investigational pill for people with type 2 diabetes whose blood sugar is not well controlled despite lifestyle changes or metformin. The pill may help improve blood sugar control and is taken by mouth.
Beijing, Beijing MunicipalityAges 18–75 - NCT07662213RecruitingPhase 3
Elecoglipron vs semaglutide for type 2 diabetes
This study tests an experimental diabetes pill (elecoglipron) to see if it works as well as a current medicine, semaglutide, for people with type 2 diabetes who also have heart risk factors. It aims to help better control blood sugar and weight.
Birmingham, AlabamaAges 18 years+
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 1 diabetes?
- Yes. Clin2 currently lists 862 recruiting type 1 diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 1 diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 1 diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.